SEARCH

SEARCH BY CITATION

References

  • 1
    Goldstein SR, Monteagudo A, Popiolek D. Evaluation of endometrial polyps. Am J Obstet Gynecol 2002;186: 669674.
  • 2
    Maia Jr H, Maltez A, Calmon LC, Coutinho EM. Comparison between suction curettage, transvaginal sonography and hysteroscopy for the diagnosis of endometrial polyps. Gynecol Endosc 1998;7: 127132.
  • 3
    Gebauer G, Hafner A, Siebzehnrubl E, Lang N. Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 2001: 5963.
  • 4
    Dewaay DJ. Natural history of uterine polyp and leiomyomata. Obstet Gynecol 2002;100: 37.
  • 5
    Mertens HJ, Heinemam MJ, Evers JL. The expression of apoptosis-related proteins Bcl-2 and Ki-67 in endometrium of ovulatory menstrual cycles. Gynecol Obstet Invest 2002;53: 224230.
  • 6
    von Rango U, Classen-Linke I, Krusche CA, Beier HM. The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 1998;13: 31693177.
  • 7
    Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of secretory phase. J Clin Endocrinol Metab 1999;84: 17371743.
  • 8
    Von Bogaert LJ. Clinical pathological findings in endometrial polyps. Obstet Gynecol 1988;71: 771773.
  • 9
    Kurman R, Mazur M. Benign diseases of endometrium. In: KurmanRJ, editor. Blaustein's Pathology of the Female Genital Tract, 4th edition. New York: Springer Verlag, 1994: 367409.
  • 10
    Gardner FJ, Konje JC, Abrams KR, et al. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intra-uterine system: a randomized controlled trial. Lancet 2000;356: 17111717.
  • 11
    Maruo T, Laog-Fernandez JB, Pakarinen P, Murakoshi H, Spitz IM, Johansson E. Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod 2001;16: 21032108.
  • 12
    Wildemeersch D, Schacht E. The effect on menstrual blood loss in women with uterine fibroid of a novel ‘frameless’ intrauterine levonorgestrel—releasing drug delivery system: a pilot study. Eur J Obstet Gynecol Reprod Biol 2002;102: 7479.
  • 13
    Maia Jr H, Maltez A, Fahel P, Coutinho EM. Hysteroscopy and immuno-histochemical findings in type I and type II endometrial carcinomas. J Am Assoc Gynecol Laparosc 2001;8: 222230.
  • 14
    Taylor LJ, Jackson TL, Reid JG, Duffy SR. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki-67 in endometrial polyps. Br J Obstet Gynaecol 2003;110(9):794798.
  • 15
    Maia Jr H, Maltez A, Athayde C, Coelho G, Coutinho EM. Detection of endometrial intraepithelial neoplasia in postmenopausal endometrium. Maturitas 2003;46(2):153161.
  • 16
    Isaksson E, Cline JM, Skoog L, et al. p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques. Breast Cancer Res Treat 1999;53: 6167.
  • 17
    Hurd C, Dinda S, Khattree N, Mouldgil VK. Estrogen dependent and independent activation of PI promoter of p53 gene in transiently transfected breast cancer cells. Oncogene 1999;18: 10671072.
  • 18
    Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001;13: 332337.
  • 19
    Huober JB, Nakamura S, Meyn R, Roth JA, Mukhopadhyay T. Oral administration of an estrogen metabolite-induced potentialization of radiation antitumor effects in the presence of wild-type p53 in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2000;48: 11271137.
  • 20
    Maia Jr H, Maltez A, Athayde C, Coelho G, Coutinho EM. P53 expression in spontaneous and estradiol induced hyperplasia during menopause. Maturitas 2003;44: 175180.
  • 21
    Quddus MR, Sung CJ, Zheng W, Lauchlan SC. P53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding. Histopathology 1999;35: 4449.
  • 22
    Bakour SH, Gupta JK, Khan KS. Risk factors associated with endometrial polyps in abnormal uterine bleeding. Int J Obstet Gynecol 2002;76: 165168.
  • 23
    Perrone G, DeAngelis C, Critelli C, et al. Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users. Maturitas 2002;43: 251255.
  • 24
    Schlesinger C, Kamoi S, Ascher SM, Kendell M, Lage JM, Silverberg S. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 1998;17: 302311.